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Abstract The epsin NH2-terminal homology (ENTH) domain
is a membrane interacting module composed by a superhelix of
K-helices. It is present at the NH2-terminus of proteins that often
contain consensus sequences for binding to clathrin coat
components and their accessory factors, and therefore function
as endocytic adaptors. ENTH domain containing proteins have
additional roles in signaling and actin regulation and may have
yet other actions in the nucleus. The ENTH domain is
structurally similar to the VHS domain. These domains define
two families of adaptor proteins which function in membrane
traffic and whose interaction with membranes is regulated, in
part, by phosphoinositides. ß 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Following the discovery of the clathrin coat in the mid-
sixties [1] major progress has been made towards its molecular
characterization. Endocytic clathrin coats, in particular, have
been thoroughly investigated [2^5]. Their main components
are the heavy and light chains of clathrin [4], and the hetero-
tetrameric clathrin adaptor AP-2 [6]. In addition, a large num-
ber of accessory factors that cooperate with clathrin and AP-2
in the endocytic reaction, and may also assist the newly
formed vesicle during the early stages of the endocytic path-
way, have been identi¢ed [3,7]. Studies of these factors, which
typically have a modular structure, led to the identi¢cation of
the EH domain, and subsequently, of the ENTH domain. EH
domains, which are discussed elsewhere in this volume [8], are
small protein modules ¢rst recognized in the NH2-terminal
region of Eps15 (Eps15 homology). Eps15 is a main substrate
for the tyrosine kinase activity of the EGF receptor [9] and is
also a major AP-2 interactor [10]. Thus, while it has a special
role in EGF receptor signaling and/or internalization, it also
participates in all forms of endocytosis, including synaptic
vesicle recycling at the synapse [11]. Studies of the EH domain
revealed that it functions as a protein^protein interaction
module and de¢ned the sequence NPF as a critical consensus
for EH domain binding [12].
2. Epsin: the founding member of ENTH domain containing
proteins
A search for interactors of the EH domains of Eps15 in
brain led to the identi¢cation of a major 90 kDa synaptically
enriched protein band (based on SDS^PAGE motility) re-
ferred to as epsin (epsin 1) (for Eps15 interacting protein)
[13]. A molecular characterization of epsin demonstrated its
identity to a 90 kDa protein band previously shown to bind
the ear domain of the clathrin adaptor AP-2 [14], thus cor-
roborating a link of this protein to the endocytic machinery.
Independently, epsin was isolated as an interactor of the EH
domains of intersectin, another accessory factor in endocyto-
sis [15,16] and of POB1, a component of the Ral GTPase
network [17]. A function of epsin in the endocytic reaction
was further con¢rmed by its property to bind clathrin [18^20]
and by evidence that disruption of epsin function in living
cells inhibits receptor-mediated endocytosis of the EGF and
transferrin receptors [13].
3. Domain structure of epsin and de¢nition of the ENTH
domain
Inspection of the epsin 1 sequence and alignment with re-
lated sequences allowed de¢nition of several major domains
within this protein [13] (Fig. 1). The NH2-terminal approxi-
mately 150 amino acids are highly conserved in evolution.
Hence, they were proposed to represent a separately folded
protein module, the epsin NH2-terminal homology (ENTH)
domain [13,21]. The remaining portion of the epsin contains
several stretches of low complexity amino acid composition
and signature motifs for binding to other endocytic proteins.
Its central region contains multiple DPW repeats [13], which
¢t the consensus DP[W/F] of the core of binding sites for the
ear domains of the K- and L-adaptin subunits of AP-2 [22]. It
also includes two consensus sequences for binding to the
heavy chain of clathrin (clathrin boxes) [4,18,20,23]. Accord-
ingly, the central region of epsin binds both AP-2 and clathrin
[18,20]. The COOH-terminal part of the protein comprises
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three NPF repeats required for binding to Eps15, intersectin
and other EH domain containing proteins [13,15,17]. Re-
cently, epsin was shown to be mono-ubiquitinated (Polo, S.,
Sigismund, S., Faretta, M., Guidi, M., Capua, R.M., Bossi,
G., Chen, H., De Camilli, P. and Di Fiore, P.P., unpublished
observation) and the sequence between the ENTH domain
and the central DPW domain was found to contain three
ubiquitin interacting motifs (UIMs) [24]. This region does
bind ubiquitin, and, surprisingly, is also needed for ubiquiti-
nation (Polo et al., see above).
At least some of the interactions of epsin are regulated by
phosphorylation. At synapses, epsin undergoes constitutive
phosphorylation and its stimulation-dependent dephosphory-
lation correlates with its assembly into endocytic complexes
[25]. Mitotic phosphorylation of epsin at serine 382 (rat epsin
1) inhibits its interaction with clathrin coat components and
possibly re£ects one of the mechanisms leading to inhibition
of clathrin-mediated endocytosis in mitotic cells [25,26]. Stud-
ies on yeast epsin homologs [27] predict that epsin may be a
substrate for GAK kinases [28], the mammalian homologs of
yeast Prk/Ark kinases implicated in actin function and endo-
cytosis [29].
4. The epsin family
Proteins that have the same overall domain structure of
epsin 1 and contain most of its signature motifs are present
in all eukaryotic organisms (Fig. 1). The human genome con-
Fig. 1. Domain cartoon of a subset of proteins containing ENTH or VHS domains. The drawing illustrates the presence in many of them of
motifs or domains which mediate an interaction with clathrin coat proteins, actin and other components of the cell cortex. See text for the sig-
ni¢cance of these domains. While only DPF/W motifs (AP-2 interaction motifs) are shown, additional DXF motifs, which may also mediate in-
teraction with AP-2, are present in some of these proteins. Orange ovals represent either sequences which ¢ts the clathrin binding consensus
(clathrin box) as de¢ned in [4,23], or closely related sequences experimentally shown to bind clathrin. Other clathrin box-like sequences, possi-
bly representing additional clathrin binding sites, are not indicated. Mammalian AP180 was shown to bind clathrin through a series of short
motifs more distantly related to typical clathrin boxes (region indicated by an orange dotted line) [37]. HIP1R binds clathrin via coiled-coil in-
teractions (region indicated by an orange continuous line) (modi¢ed from [21]).
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tains at least three epsin genes. Epsin 1 is expressed at high
concentration in brain [13], epsin 2 has a more widespread
tissue distribution [20] while epsin 3 is keratinocyte speci¢c
[30]. A Xenopus epsin was identi¢ed as a mitotic phosphopro-
tein in oocytes (MP90) [26]. One epsin orthologue, liquid fac-
ets (LqF), is present in Drosophila. Developmental defects due
to mutations in LqF are enhanced by mutations in the genes
encoding clathrin heavy chain (CHC) or the GTPase dynamin
(shibire), thus providing genetic evidence for a link between
epsin family members and endocytosis [31]. Two characterized
epsin homologs, Ent1 and Ent1, are present in Saccharomyces
cerevisiae. In these two proteins, the clathrin binding consen-
Fig. 2. Comparison of the ENTH domain of epsin 1 (magenta) with similar structures. Superposition of the ENTH domain with the VHS do-
main (green) (a), the armadillo repeat region of L-catenin (green) (b), the HEAT repeat region of importin-L (gold) (c), the ENTH domain of
CALM domain (red) (d), the ENTH domain of the LAP protein (green) (e).
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sus is localized at the COOH-terminus, downstream of the
NPF motifs, which bind yeast EH domain proteins [32].
Both Ent1 and Ent2 participate in endocytosis and in the
regulation of actin function, in agreement with strong evi-
dence linking actin to endocytosis in yeast. While neither
the ENT1 or the ENT2 gene is essential, an ent1v,ent2v dou-
ble mutant is not viable. This mutant can be rescued by a
truncated form of Ent2 that comprises the ENTH domain
and the COOH-terminal clathrin binding domain, but not
by Ent2 constructs missing the ENTH domain [32]. Thus,
the ENTH domain represents a critically important portion
of epsin.
5. Other ENTH domain containing proteins
In addition to proteins likely to be bona ¢de epsin homo-
logs, several other protein families contain an ENTH domain
(http://www.sanger.ac.uk/cgi-bin/Pfam/getacc?PF01417) (Fig.
1). While some of these proteins are substantially divergent
from epsin outside this domain, which is always localized near
the NH2-terminus, they often contain some additional ele-
ments of similarity. Thus, many such proteins contain
UIMs, DX[W,F] motifs [3], clathrin boxes or closely related
sequences, and NPF motifs [21] (Fig. 1). For two of these
protein families, the presence of an ENTH domain, predicted
by distant amino acid sequence similarity, has been con¢rmed
by crystallographic studies. One of these two families is the
AP180/CALM family of accessory clathrin adaptors. AP180 is
a third major component of neuronal endocytic clathrin coats
besides clathrin and AP-2 [33^35]. CALM is its non-neuronal
homolog [36]. Both AP180 and CALM bind AP-2 and clath-
rin. Accordingly, they contain AP-2 binding motifs [3] as well
as multiple repeats of a small amino acid stretch that contains
a core consensus similar to clathrin boxes [37]. CALM also
contains NPF motifs and bind EH domain containing pro-
teins [36]. Based on results from cell-free studies [34] and on
ultrastructural observations of AP180 mutants of Drosophila
(lap mutants) and Caenorhabditis elegans (unc11 mutants)
[38,39], AP180/CALM proteins are thought to play a role in
the generation of homogeneously sized high curvature
vesicles. Furthermore, unc11 mutants accumulate abnormal
levels of synaptobrevin/VAMP in the plasma membrane
[39], raising the possibility that AP180 may participate in
the recapture of synaptobrevin into endocytic vesicles after
endocytosis. Two ENTH containing AP180 homologs are
present in yeast: yAP180A and yAP180B. They bind clathrin
and EH domain containing proteins and have a putative role
in endocytosis and actin function [40].
The other protein family with an NH2-terminal region that
is structurally similar to the ENTH domain is the one com-
prising HIP1 and HIP1R, so called because of their property
to interact with huntingtin (huntingtin interacting protein and
huntingtin interacting protein related, respectively), the Hun-
tington disease protein. HIP1 binds AP-2 and clathrin via
typical consensus sequences (DPF or DXF and a clathrin
box respectively) [41^43], and both HIP1 and HIP1R interact
with clathrin via coiled-coil domains [42,44]. A unique feature
of HIP1 and HIP1R among ENTH domain containing pro-
teins is the presence of a talin homology domain in the
COOH-terminal region [45]. This comprises the I/LWEQ mo-
tif through which they bind actin. Thus, these two proteins,
which are partially localized on clathrin-coated pits and
vesicles, may act as linkers between clathrin coats and the
actin cytoskeleton [44,45]. The yeast homolog of HIP1/
HIP1R is the Sla2 protein, which also contains an ENTH
domain and a talin homology domain, and which is impli-
cated in actin function and endocytosis [46,47]
6. Atomic structure of the ENTH domain
The structure of the ENTH domain of epsin 1 was solved
by X-ray crystallography (Fig. 2). The ENTH domain forms a
compact globular structure, composed of eight K-helices con-
nected by loops of varying length ([48]; see also RCSB/PDB
accession number 1EDU). The general topology of the do-
main is determined by three helical hairpins that are stacked
consecutively with a right-handed twist. This stacking gives
the ENTH domain a rectangular appearance when viewed
face on [48]. The most highly conserved amino acids fall
roughly into two classes: (i) internal residues that are involved
in packing and therefore are necessary for structural integrity,
and (ii) solvent accessible residues that may be involved in
protein^protein interactions [48].
More recently, other ENTH domain structures have been
solved: the ENTH domain of rat CALM [49] (Figs. 2d and 3),
of its Drosophila homolog Lap (Fig. 2e) [50] and of Hip1R
(McMahon, H., personal communication). These ENTH do-
mains are very similar to each other in spite of low amino acid
sequence similarity (Fig. 2d,e). Only the COOH-terminal helix
of epsin’s ENTH domain does not superimpose well on the
corresponding region of CALM, but this di¡erence may re-
£ect an abnormal orientation of this helix when disconnected
from downstream regions. In the CALM construct used for
crystallographic analysis, this helix is followed by an addi-
tional K-helical stretch [49].
7. Structural neighbors of the ENTH domain
The ENTH domain is most similar in atomic structure to
the VHS domain [51^53] (Fig. 2a). The VHS and ENTH
domains align with a root mean square deviation (RMSD)
of approximately 1.8 Aî , indicating an extremely similar fold
despite low primary sequence similarity. The VHS domain,
which is discussed in another paper of this volume [54] was
¢rst identi¢ed as an NH2-terminal homology region found in
Vps27, Hrs and STAM [51] (Fig. 1). Hrs and its yeast homo-
log Vps27 have been implicated in endocytic tra⁄c. STAM is
a signal transducing adaptor molecule involved in cytokine-
mediated signaling [55]. The VHS domain is also present in
other mammalian proteins that participate in the regulation of
membrane tra⁄c to the endosome-lysosomal system either
from the plasma membrane or from the Golgi complex. These
include EAST, which, like Hrs, is a substrate for EGFR and
also binds to Eps15 [56^58], and the GGA proteins, which
function in transport from the Golgi to the lysosomes [59^
61]. As in the case of ENTH domain proteins, functional links
of VHS domain proteins to actin and signaling have been
reported [51,54]. Like the ENTH domain, the VHS domain
is always found at the NH2-terminus of proteins and can be
followed by UIM motifs [24]. In addition, some VHS and
ENTH domain proteins share some of their binding partners
(for example Eps15 and clathrin) [58,62,63] (Fig. 1).
The ENTH structure is also similar to an armadillo repeat
segment of L-catenin (Fig. 2b) [64], to the HEAT repeat unit
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of karyopherin-L (importin-L) (Fig. 2c) [65,66], and to the
sca¡olding subunit of protein phosphatase 2A [67]. Both ar-
madillo and HEAT repeats are protein^protein interaction
modules composed exclusively of K-helices, and form struc-
tures with two primary faces, one concave and one convex.
Armadillo and HEAT repeats bind to target proteins with
their concave face [64^67]. Structural superimposition of the
ENTH domain with either type of repeats aligns their concave
faces, which contain the largest patch of conserved surface
residues.
8. Interactions of the ENTH domain
The ENTH domain of AP180/CALM contains a basic ami-
no acid cluster that was shown biochemically to bind inosi-
tolpolyphosphates as well as PtdIns(4,5)P2 [49,68]. The liga-
tion of three lysines and a histidine within this cluster by
phosphate groups of the inositol ring has been con¢rmed by
crystallographic studies [49] (Fig. 3A). Surprisingly, the
ENTH domain of epsin, which lacks this basic region [49],
also binds PIP2 and PIP3 [69]. The residues of this domain
that exhibit the largest chemical shift upon phospholipid bind-
ing are not in register with the PtdIns(4,5)P2 binding amino
acids of AP180/CALM, but are on the same side of the do-
main (Fig. 3B). Although some discrepancies between the two
studies which addressed these lipid interactions must be fur-
ther addressed [49,69], it would appear that the ENTH do-
mains are phospholipid binding modules, whose a⁄nity for
phosphoinositides is further enriched in some family members
by the presence of clusters of basic amino acids. The interac-
tion with membrane phospholipids of ENTH domains must
be reversible and regulated because a major pool of these
proteins has a cytosolic localization [13,20]. We note that an
interaction with phosphoinositides was also shown for the
NH2-terminal region of the K-adaptin subunit of AP-2 [70],
which was proposed to align structurally with the NH2-termi-
nal portion of the ENTH domain of AP180/CALM (see Fig.
2G in [49]). Thus, recruitment to the lipid bilayer of the clath-
rin adaptor AP-2 and of ENTH domain proteins may be
mediated by similar mechanisms. Interestingly, the structur-
ally related VHS domain is also a phospholipid binding mod-
ule, whose interaction with membrane is further enhanced, at
least in some proteins, by £anking FYVE domains which bind
PtdIns(3)P (Fig. 1) [51^53].
Interactions of ENTH domains with proteins have been
described. The interaction of the ENTH domain of epsin 1
with the transcription factor PLZF may suggest a role of
epsin as a transcriptional regulator (see below) [48]. The
same domain also strongly interacts with tubulin in vitro
(Kay, B., McPherson, P. and Traub, L., personal communi-
cations; our unpublished results) and possibly with the coat-
omer [48], but the signi¢cance of these ¢ndings is unknown.
No interactions with transmembrane proteins have been re-
ported so far. However, the reported binding of the VHS
domain to cytoplasmic tails of membrane proteins [60,61]
raises the possibility that a similar property may also apply
to the ENTH domain.
9. ENTH domain proteins and ubiquitin
An unexpected twist in the understanding of epsin function
came with the isolation of Drosophila epsin (LqF, see above)
as an enhancer of mutations in Fat facet (Faf) [31]. Faf is a
de-ubiquitinating enzyme whose activity is necessary in a sig-
naling pathway underlying the proper development of photo-
receptor cell clusters in the eye. Genetic data suggest that
epsin may be a substrate for Faf [31]. Accordingly, epsin
has now been shown to be mono-ubiquitinated and its state
of ubiquitination is stimulated by growth factor receptor ac-
tivation (Polo et al., see above). It remains unclear whether
ubiquitination^de-ubiquitination of epsin is a mechanism to
control its half-life, or to regulate its interactions and local-
ization. Since ubiquitination of membrane associated proteins
mediate their targeting to lysosomes, ubiquitination may
Fig. 3. Proposed PtdIns(4,5)P2 binding sites in the ENTH domain.
A: Superposition of the ENTH crystal structure (magenta) [48] and
the crystal structure of the CALM protein (red) [49]. Residues that
are involved in PtdIns(4,5)P2 binding to CALM [49] are explicitly
shown as sticks. B: Superposition of epsin’s ENTH crystal structure
(magenta) [48] and its solution NMR structure (red) [69]. Residues
that are implied in PtdIns(4,5)P2 binding (Fig. 2g of [69]) are explic-
itly shown as sticks.
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underlie a post-internalization function of epsin in the endo-
cytic pathway [71,72]. A further link between epsin and ubiq-
uitin metabolism has been revealed by the identi¢cation of
UIMs in epsin and other ENTH and VHS domain containing
proteins [24] and by the demonstration that the UIMs of epsin
bind ubiquitin (Polo et al., see above).
10. Nuclear cytoplasmic shuttling of ENTH domain proteins
Epsin and other well-characterized ENTH domain contain-
ing proteins are localized at the cell periphery, in proximity of
endocytic sites, actin and signaling sca¡olds [13,44,45,49]. Yet,
incubation of cells with leptomycin, a fungal metabolite that
inhibits the Crm1-dependent nuclear export pathway, leads to
the rapid accumulation of both epsin and CALM in the nu-
cleus, suggesting that these ENTH domain containing pro-
teins continuously shuttle in and out of the nuclear envelope
[48,73]. A similar shuttling, involving a reversible binding to
Ran GTPases, has been demonstrated for Eps15 [73]. Epsin
does not contain a conventional nuclear localization sequence,
but it is interesting to note that its ENTH domain shares
some similarity to the karyopherin/importins (see above)
(Fig. 2c). Furthermore, L-catenin, another structural neighbor
of the ENTH domain (Fig. 2b) and of karyopherin, also
shuttles in and out of the nucleus but lacks a classical nuclear
localization sequence. The list of proteins with a main func-
tion in the cortical region of the cell, but which also have a
second life in the nucleus as transcriptional regulators, is rap-
idly increasing (for example [74^77]). They include actin [78]
and proteins that, like epsin, can bind both plasma membrane
phospholipids and transcription factors. One well-character-
ized such example is tubby [79]. Perhaps, this dual localization
re£ects an origin of the nuclear matrix from a prokaryotic
cortical cytoskeleton that acts as a sca¡old for DNA. In eu-
karyotic cells, where the DNA has been segregated from the
cytoplasm by the nuclear envelope, nuclear cytoplasmic shut-
tling of proteins of the cell cortex may play an important role
in mediating a signaling feed-back between the transcriptional
machinery and changes in the extracellular environment.
11. Putative adaptor function of ENTH domain containing
proteins
Based on their structural properties and interaction, as well
as on the phenotype resulting from their functional disrup-
tion, it appears that a main function of the majority of
ENTH domain containing proteins is to act as accessory
clathrin adaptors in endocytosis (Fig. 4). Thus, they bind to
the phospholipid bilayer, and help recruiting clathrin coat
components and EH domain containing clathrin accessory
factors, such as Eps15 and intersectin. Consistent with this
hypothesis, AP180 and CALM are enriched in clathrin-coated
vesicles [13,33] and disruption of AP180 at the synapse leads
to defects in the clathrin-dependent endocytosis of synaptic
vesicles. An accumulation at clathrin-coated pits was also ob-
served for epsin [13,20], HIP1 [41] and HIP1R [44], although
the recovery if these proteins in puri¢ed clathrin-coated vesicle
fractions is variable [13,80], possibly depending, in part, upon
the variable preservation of phosphoinositides on the vesicle
membrane. A similar clathrin adaptor function has been dem-
onstrated for one class of VHS domain proteins, the GGA
proteins, which comprise an adaptin homology region and
clathrin binding sites. The VHS domain of the GGA proteins
not only binds phospholipids but also cytoplasmic tails of
vesicle cargo proteins, thus participating in cargo selection
[60,61]. An interesting possibility, to be explored by future
studies, is that ENTH domains as well may interact with
the cytosolic tail of membrane proteins and thus contribute
to the sorting of cargo transmembrane proteins into budding
vesicles. Via interactions with clathrin accessory factors such
as Eps15, intersectin and POB1, ENTH domain proteins may
help to coordinate the endocytic reaction with a local reor-
ganization of the actin cytoskeleton and of signaling sca¡olds.
Mono-ubiquitination of the cytoplasmic tails of several
membrane proteins has been shown to be important for their
internalization [81]. UIMs may interact with their ubiquiti-
nated tails and thus contribute both to the selection of these
proteins as cargo for the nascent vesicle and to the recruit-
ment of ENTH domain containing proteins to the membrane
(Fig. 4). An additional function of UIMs may be to bind
ubiquitin-loaded E3 enzymes, thus facilitating the ubiquitina-
tion of ENTH domain proteins (Polo et al., see above). Sup-
port to the second possibility comes from essential require-
ment for the UIMs in the mono-ubiquitination of epsin and of
other UIM domain containing proteins tested (Eps15 and
Hrs) (Polo et al., see above). In either case, presence of ubiq-
uitinated ENTH domain proteins on internalized vesicles may
help to direct them to the endosome-lysosomal system [71,72].
UIMs are also present in VHS domain containing proteins,
which may additionally contain the FYVE domain, a
PtdIns(3)P binding module (see Stenmark et al. [63]). Thus,
phosphoinositides and membrane-bound ubiquitin may func-
Fig. 4. Interactions of epsin illustrating its putative adaptor function. The ‘so called’ DPW domain include both DPW repeats and two clathrin
boxes [20]. While the interaction of epsin’s UIM domain with ubiquitin has been documented (Polo et al., see text), it remains unclear whether
epsin does bind ubiquitinated protein cargo of clathrin-coated vesicles. It is also unclear whether the ubiquitination of epsin, which requires an
intact UIM, interferes with the ubiquitin binding properties of the UIM. U = ubiquitin.
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tion as membrane coreceptors for both VHS and ENTH do-
main containing proteins. While the predominant phospho-
inositide on the plasma membrane and nascent endocytic
vesicles is PtdIns(4,5)P2, an important phosphoinositide on
endosomes is PtdIns(3)P. It is therefore of interest that
ENTH domain containing proteins appear to be involved in
the endocytic reaction, while Hrs, which contains a VHS do-
main followed by the FYVE domain is implicated in down-
stream stations of the endocytic pathway. A progressive shift
from an ENTH-based membrane associated sca¡old to a
VHS-FYVE domain-based sca¡old may occur along the en-
docytic pathway.
12. Conclusions and future perspectives
ENTH domain containing proteins have come to center
stage in cell biology as important cross-roads of many di¡er-
ent areas of cell biology. The ENTH domain is a membrane
interacting module which is found in a variety of proteins
whose shared characteristic is to act at early stages of the
endocytic pathway as coat components and coat adaptors.
These proteins have additional roles in signaling and actin
regulation. Their further characterization may help shed light
on the elusive link between actin and endocytosis. Priorities
for future research include a precise elucidation of the link of
ENTH domain containing proteins to ubiquitin metabolism
and an understanding of how the multiple interactions of
these proteins are regulated. A well-coordinated sequence of
conformational changes and posttranslational modi¢cation is
likely to be essential for a proper function of these proteins in
the context of the cell cytoplasm.
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